• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s lead clinical late stage programs address hospital and healthcare associated infections.

  • Valneva covers the full value chain from research to market.

 

Welcome to Valneva

A leading pure play vaccine company.

2015 Annual Business Report

— August 31, 2016

Valneva Reports Strong Revenue Growth and Positive EBITDA in H1 Confirming the Company’s Trend towards EBITDA Break-even
Read more

— Stock information

— Financial Calendar



August 31, 2016
Valneva published its Q2/H1 2016 financial results today. A conference call will be held at 2 pm (CET) and can be accessed here.

See all dates

AKTUELLES

News in German


 

VALNEVA
LIBRARY

Images, presentations and videos

JAPANESE
ENCEPHALITIS
AND
CHOLERA




learn more
play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs



Rodman & Renshaw 18th Annual Global Investment Conference
New York, US
September 11-13, 2016










map

A leading pure play vaccine company with international footprint.

Locations
Please update your browser...